New Non-Invasive Keloid Treatment using Rhenium-188 now available in South Africa

May 4, 2021

Province of Gauteng South Africa is first to offer an innovative single session keloid treatment without need of surgery

GARCHING, MUNICH, Germany & GAUTENG, South Africa - May 4, 2021 - PRLog -- OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies, announced today that the new Rhenium-188 treatment for keloids is now available in Gauteng, South Africa.

Even though keloids are common throughout the world, their epidemiology has not been adequately investigated. The development of Keloid scars is not only a cosmetic issue but also sometimes painful or limit mobility and may cause deterioration in the quality of life.
The incidence of Keloids in South Africa is very high. According to research in Nigeria, Zambia & South Africa have shown incidence rates are as high as 16% (over 9 million). Some skin types are more prone to Keloids than others, but all can be affected.

Severe cases of Keloids are usually treated by surgery followed by radiation and the prolonged daily use of corticosteroid tape/bandages; however, they tend to recur when they are surgically excised in the absence of adjuvant therapies.

The new Rhenium-188 therapy is now available for Keloid sufferers in South Africa and will be provided by Oncobeta's distribution partner Tautomer (PTY) LTD. This next-generation radionuclide therapy technology applied by nuclear medicine physicians, offers a new single session, painless and effective treatment for keloids. This technology has also been used successfully to date for the treatment of Non-Melanoma skin cancers.

Martin Magwaza, CEO of Tautomer (PTY) LTD also Oncobeta®'s distribution partner for the Rhenium-SCT® (Skin Cancer Therapy) in Africa, is dedicated to providing South Africans with new innovative and effective therapies across the country and African continent, coordinating with representatives from all levels of government and state for the health care landscape.

CEO and Managing Director of OncoBeta® GmbH, Shannon D. Brown III stated "Our ground-breaking technology brings a fantastic new treatment opportunity for people suffering from keloids. It also shows what great potential Rhenium-188 has in the epidermal treatment realm."

About Rhenium-188 treatment
The Rhenium-188 paste is a brachytherapy utilizing the Beta emitter radioisotope Rhenium-188 for epidermal treatments. Rhenium-188 is an isotope with excellent therapeutic advantages that delivers ß-radiation to lesions and minimum dose to the surrounding tissue due to its low penetration in the human tissue (only up to 2-3 mm).
The Rhenium-188 epidermal radioisotope therapy is a painless, personalized, non-invasive therapy targeting and destroying the cells in the area needed to treat. This triggers the treated area to discard defective cells and initiate local immune system reactions letting the body repair itself.

About Tautomer (PTY) LTD

Tautomer is a privately owned, fully integrated Health Technology company based in Centurion, South Africa. Through our network of strategic partners, we engage in the development, manufacturing, and distribution of high-quality Nuclear Medicine based therapies and diagnostics. Tautomer has an extensive pipeline of product candidates under development for various therapeutic indications. The primary focus of Tautomer is to address the unmet medical needs in Oncology, Pain Management, Infectious diseases. Also leveraging scientific and technological advancements to develop solutions that can help expand treatment options for healthcare practitioners and patients in Africa and beyond.

Find out more about Tautomer at https://tautomer.co.za/

About OncoBeta® GmbH
OncoBeta® GmbH with its headquarters located in Garching near Munich, is a privately held medical device company, specializing in the development and commercialization of state-of-the-art, innovative epidermal radioisotope therapies. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of therapies such as the Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers and is now expanding to other epidermal indications such as Keloids. OncoBeta® has successfully perfected the customized application and device management system to perform these therapies in conformity with all health, safety, and environmental protection regulatory standards.

Find out more about OncoBeta® at https://www.oncobeta.com/

Contact
OncoBeta GmbH
[email protected]
+49 (89) 32667330


Photos: (Click photo to enlarge)



Read Full Story - New Non-Invasive Keloid Treatment using Rhenium-188 now available in South Africa | More news from this source

Press release distribution by PRLog

More News

Putting skin recovery at the heart of beauty care

Oct 30, 2026

Putting skin recovery at the heart of beauty care

Skin recovery took center stage at a gathering of dermatologists, cosmetic surgeons and aesthetic practitioners in Taguig City, where a discussion on barrier care connected skincare science with the experiences and professional interests of the medical community. Held on October 21 at the Intramuros Tent of Manila House Private Club in Bonifacio Global City, the roundtable discussion brought together the Pan Pacific Aesthetic Institute Foundation, Lamelex, Golden Visa Central and Manila House. Their collaboration provided a setting for scientific learning, professional exchange and conversations about opportunities beyond clinical practice. For the beauty discussion, the emphasis was on caring for the skin barrier, particularly after dermatologic and aesthetic procedures. Dr. Finesse Angelica Evangelista addressed this in her presentation, “The Science of Recovery: Optimizing Barrier Repair in Post-Procedure and Compromised Skin.” Her discussion underscored the importance of skin barrier integrity in supporting recovery. It also placed barrier-focused care within a professional conversation about the needs of skin following procedures or when its condition is compromised. That focus is central to Lamelex’s approach. The brand presented its multi-lamellar vesicle technology, a skincare delivery approach designed to support the skin’s natural barrier structure and in­gre­­­­d­ient delivery. Its professional skincare offe­rings combine formulations and protocols intended for barrier-focused care. The technology formed part of the brand’s showcase, which included professional skincare products, testers, merchandising and educational materials. These gave participants opportunities to explore its approach to skin barrier care alongside the scientific discussion. Medical professionals also received product kits for further exploration and evaluation in their respective practices. Catherine Andres-Gamo, chief exe­cutive officer of Pretty Skin Lamelin Philippines, expanded the conversation from products to advocacy. Sha­ring Lamelex’s commitment to scientific education, skincare innovation and collaboration with the medical community, she encouraged participants to become skin barrier advocates. Her message called for greater awareness of barrier-first skincare in clinical practice, linking the brand’s educational efforts with the professionals who assess and care for patients’ skin. The evening brought that advocacy into direct conversation with dermatologists, cosmetic surgeons and other aesthetic practitioners. The foundation, meanwhile, provided a platform for professional exchange within the aesthetic medical community. Manila House hosted the gathering, bringing professionals from different fields into a shared setting for learning and relationship building. Alongside the skincare discussions, Golden Visa Central founder and president Vicky Luis introduced international investment opportunities and wealth diversification. Her presentation offered participants perspectives on long-term financial planning beyond their clinical work, extending the evening’s scope to their broader professional and personal interests. The gathering linked these different areas through partnerships among the foundation’s leadership, Golden Visa Central, Manila House and the Lamelex team. Each contributed expertise to a forum that combined clinical interests with opportunities for professional growth. For Lamelex, the continuing direction is to build its community of skin barrier advocates through scientific education and continued collaboration with medical professionals. The roundtable provided one setting for that exchange, bringing its products, technology and barrier-care message to practitioners who could explore and evaluate them for use in their respective practices.

Jewelry for every side of a woman

Oct 30, 2026

Jewelry for every side of a woman

Jewelry passed from mother to daughter carries more than gemstones and gold. For designer Kristine Dee, it also holds the stories behind each piece, including her mother’s purchase to celebrate a hard-earned business deal. Those personal connections inspire “Modern Heirloom,” one of three chapters in “The Woman Within,” her collection exploring the different sides of a woman through fine jewelry. Its three chapters, “Modern Heirloom,” “Quiet Strength” and “Playful Femininity,” move from sentiment to assurance to joy. Each reflects a side of a woman that Dee has observed in her clients and herself. “They try out other styles which are not their usual, and the choice follows their emotions, what they felt at that time, how that particular jewelry piece made them feel when worn. Each capsule collection shows the different versions we, as women, find ourselves in.” For “Modern Heirloom,” Dee draws on her mother Elizabeth’s practice of passing jewelry to her daughters, along with the memories behind it. Among them is a piece Elizabeth bought after closing a business deal she had worked hard to secure. “It is not just the piece that she shared, but the story that comes with them,” Dee says. That sense of continuity takes shape in classic gemstones and versatile designs. Multicolored sapphire and diamond necklaces hang from substantial gold-ball chains. A pearl necklace features diamonds and a detachable kunzite centerpiece, allowing the wearer to move between dressier and more casual looks. “Quiet Strength” turns toward architecture, emphasizing line, proportion and structure. Smooth gold surfaces, curves and carefully placed diamonds give rings and cuffs their presence. Dee’s background in industrial design informs this attention to form and how a piece sits on the body. “Each millimeter matters,” she says. A softer mood emerges in “Playful Femininity.” Mint tourmaline, pink spinel and diamonds appear in linked elements that sway with the wearer, while a coordinating ring allows for stacking. Elsewhere, a hand-carved mother-of-pearl ribbon flows into waves of rubies and diamonds. Across the collection, gemstones are set in 14-karat and 18-karat white, yellow and rose gold. Many designs bear the names of loyal clients, relatives and friends, extending the personal connections behind the jewelry. For Dee, their place is in everyday wardrobes. Statement necklaces can accompany a tank top and jeans or a dress, while rings and cuffs can be layered to suit the day. “The best way to style fine jewelry for a woman is based on her lifestyle and personality, so she can reach for them day after day, comfortably and confidently, and wear them in more ways than one.” The collection is available at the Kristine Dee showroom in BGC, Taguig City, with resizing and customization offered. A Power Plant Mall pop-up runs from Nov. 7 to Jan. 28, 2027, bringing the collection’s expressions of memory, strength and joy into women’s daily choices.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.